Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
2004 2
2006 4
2008 4
2009 5
2010 1
2013 1
2014 2
2015 1
2016 5
2017 3
2018 4
2019 2
2020 2
2021 5
2022 3
2023 5
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Pandemrix™ and narcolepsy: A critical appraisal of the observational studies.
Verstraeten T, Cohet C, Dos Santos G, Ferreira GL, Bollaerts K, Bauchau V, Shinde V. Verstraeten T, et al. Among authors: cohet c. Hum Vaccin Immunother. 2016;12(1):187-93. doi: 10.1080/21645515.2015.1068486. Epub 2015 Sep 17. Hum Vaccin Immunother. 2016. PMID: 26379011 Free PMC article. Review.
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China.
Yang J, Welby S, Liu Z, Deng S, Liu G, Meng R, Yang Y, Sun Y, He Y, Jiang N, Wu Z, Liu K, Rosillon D, Cohet C, Zhan S. Yang J, et al. Among authors: cohet c. Hum Vaccin Immunother. 2024 Dec 31;20(1):2378535. doi: 10.1080/21645515.2024.2378535. Epub 2024 Oct 17. Hum Vaccin Immunother. 2024. PMID: 39693187 Free PMC article.
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
Cohet C, van der Most R, Bauchau V, Bekkat-Berkani R, Doherty TM, Schuind A, Tavares Da Silva F, Rappuoli R, Garçon N, Innis BL. Cohet C, et al. Vaccine. 2019 May 21;37(23):3006-3021. doi: 10.1016/j.vaccine.2019.04.048. Epub 2019 Apr 25. Vaccine. 2019. PMID: 31031030 Free article. Review.
Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives.
Beck AE, Kampman M, Huynh C, Simon C, Plueschke K, Cohet C, Verpillat P, Robinson K, Arlett P. Beck AE, et al. Among authors: cohet c. Clin Pharmacol Ther. 2025 Feb;117(2):368-373. doi: 10.1002/cpt.3457. Epub 2024 Oct 21. Clin Pharmacol Ther. 2025. PMID: 39434493 Free PMC article. Review.
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study.
Gonzalez Dorta H, Verbeeck J, Crevecoeur J, Morales DR, Loedy N, Cohet C, Willem L, Molenberghs G, Hens N, Kurz X, Quinten C, Abrams S. Gonzalez Dorta H, et al. Among authors: cohet c. Lancet Digit Health. 2025 May;7(5):100861. doi: 10.1016/j.landig.2025.02.001. Epub 2025 Apr 8. Lancet Digit Health. 2025. PMID: 40204579 Free article.
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.
Moseley J, Vamvakas S, Berntgen M, Cave A, Kurz X, Arlett P, Acha V, Bennett S, Cohet C, Corriol-Rohou S, Du Four E, Lamoril C, Langeneckert A, Koban M, Pasté M, Sandler S, Van Baelen K, Cangini A, García S, Obach M, Gimenez Garcia E, Varela Lema L, Jauhonen HM, Rannanheimo P, Morrison D, Van De Casteele M, Strömgren A, Viberg A, Makady A, Guilhaume C. Moseley J, et al. Among authors: cohet c. Br J Clin Pharmacol. 2020 Jun;86(6):1034-1051. doi: 10.1111/bcp.14279. Epub 2020 Apr 24. Br J Clin Pharmacol. 2020. PMID: 32162368 Free PMC article. Review.
53 results